Sanofi, GSK get Indian approval for trial of COVID-19 vaccine
- 08-Jul-2021
Sanofi and GlaxoSmithKline have received an approval from Indian authorities for a late-stage clinical trial of their protein-based COVID-19 vaccine candidate, the drugmakers said on Thursday. France’s Sanofi and Britain’s GSK in May kicked off global trials to include more than 35,000 adults to test the shot. They hope to get approvals by the end […]
Sanofi’s confidence in its COVID-19 vaccine candidates has increased this summer
- 29-Aug-2020
The company is working on two of the more than 150 potential vaccines being developed across the world to tackle the COVID-19 pandemic
Britain nears US$625 million Sanofi/GSK COVID-19 vaccine deal: report
- 06-Jul-2020
Britain is close to a 500 million pound ($624 million) supply deal with Sanofi and GlaxoSmithKline for 60 million doses of a potential COVID-19 vaccine.
Top pharma eyes approval of COVID-19 vaccine by first half of 2021
- 23-Jun-2020
There are currently no vaccines to prevent the coronavirus that has infected more than 9 million people and killed over 469,000 globally
Pharma firm investigated over epilepsy drug linked to birth defects
- 04-Feb-2020
Sanofi said on Tuesday it was being investigated over Depakine, an epilepsy drug which caused birth malfunctions
Drugmakers hike prices on over 200 drugs
- 01-Jan-2020
Drugmakers including Pfizer, GlaxoSmithKline (GSK) and Sanofi are planning to hike U.S. list prices on more than 200 drugs in the United States on Wednesday
No carcinogen found in alternatives of Zantac: US FDA
- 24-Oct-2019
The US Food and Drug Administration said on Wednesday that alternatives to popular heartburn drug Zantac and its generic versions
Philippines to charge drugmaker, govt over dengue deaths
- 01-Mar-2019
The Philippine Department of Justice found probable cause to indict officials from a drugmaker and former and current Philippine health officials over a series of deaths related to a dengue vaccine
Our pills don’t cause racism, drugmaker Sanofi tells Roseanne
- 30-May-2018
Pulled off air over a racist tweet, US sitcom star Roseanne Barr has blamed her outburst on a sleeping pill prompting a swift retort from pharma giant Sanofi.
Sanofi digs deep to buy US haemophilia group Bioverativ for $11.6 billion
- 22-Jan-2018
PARIS: French healthcare group Sanofi has agreed to buy US haemophilia specialist Bioverativ for $11.6 billion, its biggest deal for seven years, which it said would strengthen its presence in treatments for rare diseases. Sanofi shares fell 3.4 percent by 0920 GMT, making the stock the worst performer on France’s benchmark CAC-40 index and several […]